Detalhe da pesquisa
1.
Inflammatory profile of lower risk myelodysplastic syndromes.
Br J Haematol
; 2024 May 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38772913
2.
Invasive fusariosis in acute leukaemia patients-An outbreak in the haematology ward.
Mycoses
; 66(8): 705-710, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37128958
3.
Impact of treatment with iron chelation therapy in patients with lower-risk myelodysplastic syndromes participating in the European MDS registry.
Haematologica
; 105(3): 640-651, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31278207
4.
Impact of red blood cell transfusion dose density on progression-free survival in patients with lower-risk myelodysplastic syndromes.
Haematologica
; 105(3): 632-639, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31171638
5.
Increased Dkk-1 plasma levels may discriminate disease subtypes in myeloproliferative neoplasms.
J Cell Mol Med
; 22(8): 4005-4011, 2018 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-29975001
6.
Labile plasma iron levels predict survival in patients with lower-risk myelodysplastic syndromes.
Haematologica
; 103(1): 69-79, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29122992
7.
Cytomorphology review of 100 newly diagnosed lower-risk MDS patients in the European LeukemiaNet MDS (EUMDS) registry reveals a high inter-observer concordance.
Ann Hematol
; 96(7): 1105-1112, 2017 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-28526957
8.
Cooccurring JAK2 V617F and R1063H mutations increase JAK2 signaling and neutrophilia in myeloproliferative neoplasms.
Blood
; 132(25): 2695-2699, 2018 12 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-30377194
9.
Novel dynamic outcome indicators and clinical endpoints in myelodysplastic syndrome; the European LeukemiaNet MDS Registry and MDS-RIGHT project perspective.
Haematologica
; 105(11): 2516-2523, 2020 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33054132
10.
Acute Promyelocytic Leukemia: Review of Complications Related to All-Trans Retinoic Acid and Arsenic Trioxide Therapy.
Cancers (Basel)
; 16(6)2024 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38539495
11.
Case report: High-risk acute promyelocytic leukemia and COVID-19-related myocarditis one patient, two cytokine storms.
Front Oncol
; 13: 1095154, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37114131
12.
Health-related quality of life in lower-risk MDS patients compared with age- and sex-matched reference populations: a European LeukemiaNet study.
Leukemia
; 32(6): 1380-1392, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29572506
13.
Early platelet count kinetics has prognostic value in lower-risk myelodysplastic syndromes.
Blood Adv
; 2(16): 2079-2089, 2018 08 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-30126931
14.
Prognostic impact of a suboptimal number of analyzed metaphases in normal karyotype lower-risk MDS.
Leuk Res
; 67: 21-26, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29407183
15.
Toxic iron species in lower-risk myelodysplastic syndrome patients: course of disease and effects on outcome.
Leukemia
; 35(6): 1745-1750, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32948844
16.
Refractory anemia with ringed sideroblasts and thrombocytosis without JAK2 V617F mutation: report of three cases.
Rom J Morphol Embryol
; 54(4): 1177-82, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-24399021
17.
Epidemiological data from the registry of patients with myelodysplastic syndrome in a single hospital center of Romania.
Leuk Res
; 33(11): 1556-61, 2009 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-19411107